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INTRODUCTION
Eccrine spiradenomas were fi  rst reported as rare, 
benign, adnexal tumors of the skin in 1956 (1). Eccrine 
spiradenomas typically present as painful, slow-growing, 
solitary masses on the head or upper trunk, and they usually 
occur during the fourth or fi  fth decade of life, and without 
a predilection for either gender (2). Eccrine spiradenomas 
in the breast are very rare (2) and little is known about the 
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corresponding radiologic fi  ndings. We report here on the 
case of an eccrine spiradenoma in the breast of a 47-year-
old woman and we present the mammography, ultrasound 
(US) and breast MRI fi  ndings. 
CASE REPORT
A 47-year-old woman sought evaluation at our hospital 
for a palpable and occasionally painful lump that had been 
gradually increasing in size and it had persisted for three 
years in the left breast. The physical examination revealed 
a tender, movable, palpable mass in the left upper breast. 
Mammography demonstrated a well-defi  ned, isodense mass 
in the left upper center quadrant (Fig. 1A, B). A breast US 
exam showed three well-defi  ned hypoechoic masses in the 
subcutaneous layer. The lesions had fi  rst been noticed three 
years previously, and at that time the lesions were thought 
to be benign masses such as epidermal inclusion cysts on 
breast US due to the imaging fi  ndings and their superfi  cial 
location in the skin and subcutaneous layer (Fig. 1C). It Korean J Radiol 12(2), Mar/Apr 2011 www.kjronline.org 257
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The patient then underwent surgical excision for pain 
relief and due to the potential for malignancy. The surgical 
specimen showed superfi  cially located masses in the breast 
that each measured approximately 1 cm in size (Fig. 1I). 
Microscopy demonstrated the presence of masses in the 
dermis without obvious continuity with the epidermis 
(Fig. 1J). A histologic examination showed a characteristic 
biphasic population of outer small cells with darkly staining 
nuclei surrounding larger cells with pale cytoplasm and 
tightly packed cells arranged in a jigsaw puzzle pattern 
without epidermal connections (Fig. 1K). A histopathologic 
examination confi  rmed the diagnosis of a benign, adnexal 
skin tumor in the breast, and this was all consistent with 
an eccrine spiradenoma.
was recommended that the patient undergo routine follow-
up. The current US examination demonstrated an apparent 
increase in the size of the masses as compared to that seen 
on the breast US examination performed three years earlier 
(Fig. 1D), and the lesions were shown to be solid rather 
than cystic. The patient underwent an US-guided 14-gauge 
core needle biopsy for pathologic evaluation. The pathologic 
fi  ndings on core needle biopsy were consistent with an 
eccrine spiradenoma of the breast. A breast MRI exam using 
a dedicated bilateral breast coil showed low signal intensity 
on the T1-weighted images, low- to intermediate-signal 
intensity on the T2-wighted turbo spin echo images, high 
signal intensity on the turbo inversion recovery magnitude 
(TIRM) sequence and homogeneous enhancement on the 
gadolinium-enhanced T1-weighted images (Fig. 1E-H). 
A B 
Fig. 1. Eccrine spiradenoma arising in 
breast in 47-year-old woman.
A, B. Routine mammography was performed 
and this showed two well-defi  ned nodular 
densities in left upper central quadrant.
C, D. Breast US was performed on fi  rst visit 
three years previously (C). US demonstrated 
presence of three well-defi  ned, oval-
shaped, homogenously hypoechoic masses 
within skin layer (white stars), with sizes 
of 9 × 4 mm, 8 × 5 mm and 4 × 2 mm, and 
mild posterior acoustic enhancement. As 
compared to previous US, current breast 
US (D) shows presence of masses that have 
apparently increased in size in skin and 
subcutaneous layer. Maximum diameter of 
masses had increased from 9 to 17 mm and 
from 8 to 9 mm. More importantly, three 
masses are surrounded by echogenic lines 
(white arrows) that represent dermal layer. 
This appearance suggests cutaneous lesion.
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Fig. 1. Eccrine spiradenoma arising in breast in 47-year-old 
woman.
E-H. Breast MRI demonstrates well-defi  ned masses in left breast with 
low signal intensity on axial T1-weighted images (repetition time [TR]/
echo time [TE]: 4.6/1.7) (E), intermediate- to low-signal intensity 
on T2-weighted turbo spin echo (TSE) images (TR/TE: 3800/90) 
(F), high signal intensity on turbo inversion recovery magnitude 
image (TIRM, TR/TE/inversion time [TI]: 5620/88/230) (G), and fat-
suppressed gadolinium-enhanced T1-wighted image shows masses with 
homogeneous enhancement and linear structure that is biopsy needle 
track from skin to masses (H). I. Surgical specimen is 3.8 × 3.0 × 2.0 
cm skin tissue specimen attached to breast tissue. There are two well-
defi  ned, yellow-white solid masses, 1.4 × 1.0 × 0.8 cm and 1.0 × 1.0 × 
0.8 cm in size (arrows).J, K. Photomicrograph of specimen (Hematoxylin 
& Eosin staining) demonstrates eccrine spiradenoma composed of 
characteristic double population of outer small cells with darkly 
staining nuclei surrounding larger cells with pale cytoplasm and tightly 
packed cells arranged in jigsaw puzzle pattern without epidermal 
connections (original magnifi  cation, × 100 & × 400, respectively).Korean J Radiol 12(2), Mar/Apr 2011 www.kjronline.org 259
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DISCUSSION
Eccrine spiradenomas are benign tumors of the sweat 
glands and they are characteristically located in the 
superfi  cial and deep dermis. Eccrine spiradenomas have 
no gender predilection, they usually occur on the trunk 
or extremities, they are 1-2 cm in size and they are 
occasionally associated with pain and tenderness (3). 
Eccrine glands are present throughout the skin, but they 
are most frequent on the palms, soles and axillae. The 
majority of eccrine spiradenomas involve the trunk and 
extremities; lesions involving the breast are very rare (4). 
Of note, malignant changes and systemic metastasis of 
eccrine spiradenoma of the breast have been reported (2, 3). 
Malignant changes of an eccrine spiradenoma are extremely 
rare (2) and they generally arise from long-standing benign 
eccrine spiradenomas. To diagnose an eccrine spiradenoma, 
a biopsy should be obtained for pathologic evaluation (5). 
An eccrine spiradenoma is a highly cellular, cutaneous 
and subcutaneous tissue tumor with clear margins and it 
is composed of two types of cells (small, dark-staining 
basaloid cells and larger pale-staining cells). At low power 
magnifi  cation, a spiradenoma appears as a solid neoplasm 
composed of a single mass or a few masses of basaliod 
cells. At higher magnifi  cation, two distinct populations of 
neoplastic epithelial cells can be seen as dark and pale cells 
(6). 
A few classic cases of eccrine spiradenomas have 
been reported (3, 6). However, the imaging fi  ndings of 
eccrine spiradenomas of the breast have not been clearly 
demonstrated because of the rare incidence of eccrine 
spiradenomas and the lack of imaging studies. In 2008, 
Jin et al. (7) reported the US fi  ndings of an eccrine 
spiradenoma in the upper arm that revealed a well-defi  ned 
lobulating mass with heterogeneous hypoechogenicity in 
the deep portion of the dermis and superfi  cial subcutaneous 
fat layer without connections to the epidermis, and there 
was no extension into the muscular structures. The imaging 
fi  ndings of our case corresponded well with the imaging 
fi  ndings reported by Jin et al. (7). The US fi  ndings of the 
current case were characterized as well-circumscribed, 
oval-shaped, hypoechoic masses in the cutaneous and 
subcutaneous layer, and all the masses were surrounded by 
echogenic lines that represent the dermal layer, which are 
fi  ndings suggestive of a cutaneous origin. The lesion in our 
patient was fi  rst diagnosed as an epidermal inclusion cyst 
based on the images and the masses’ superfi  cial location. 
Epidermal inclusion cysts are well-defi  ned, round- or oval-
shaped, iso- or hyper-dense masses on mammography; 
the US fi  ndings also include round- or oval-shaped, well-
demarcated masses with variable echogenicity (hypo- or 
hyper-echogenicity) due to variable amounts of keratin 
debris, and epidermal inclusion cysts are superfi  cially 
located in the cutaneous or subcutaneous layers. Posterior 
acoustic enhancements are common, but epidermal 
inclusion cysts frequently mimic solid masses due to their 
variable echogenicity. It is diffi  cult to differentiate eccrine 
spiradenomas from epidermal inclusion cysts based solely on 
mammographic and US imaging studies due to their similar 
appearance on imaging and their superfi  cial location. 
Usually, epidermal inclusion cysts are not recommended 
for fi  ne needle aspiration or a core needle biopsy because 
the contents, which can leak out after needle biopsy, 
often irritate the surrounding tissues and they evokes an 
infl  ammatory response, and an abscess may also occur; 
however, a biopsy is needed to pathologically diagnose an 
eccrine spiradenoma. 
Only one study (6) has reported the MRI appearance of 
multiple eccrine spiradenomas that were distributed in the 
trunk, face and extremities. Cystic or solid masses with 
low signal intensity on the T1-weighted images and high 
signal intensity on the short T1 inversion recovery images 
were seen. Thus far, there have been no MRI reports of 
eccrine spiradenomas in the breast. In the case presented 
herein, the MR images showed low signal intensity on the 
T1-weighted images, high signal intensity on the TIRM 
images and intermediate- to low-signal intensity on the T2-
weighted images with homogeneous enhancement on the 
T1-weighted enhanced images. In the differential diagnosis 
of epidermal inclusion cysts, Hong et al. (8) reported that 
subcutaneous epidermal inclusion cysts in the trunk and 
extremities showed slightly high signal intensity on the 
T1-weighted images with some bright foci, a high signal 
intensity background with variable low signal components 
on the T2-weighted images and peripheral thin rim 
enhancement on the fat-suppressed T1-weighted enhanced 
images; the study by Hong et al. (8) is the largest series of 
MR images of pathologically-confi  rmed epidermal inclusion 
cysts. The signal intensities of epidermal inclusion cysts 
might be the result of the cystic content fi  lled with keratin 
materials and bounded by a wall of stratifi  ed squamous 
epithelium. An epidermal inclusion cyst is more likely 
than another subcutaneous lesion when the T2-weighted 
image shows variable low signal components within the Korean J Radiol 12(2), Mar/Apr 2011 www.kjronline.org 260
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lesion. According to Hong et al. (8) and the current case, 
the MRI fi  ndings of epidermal inclusion cysts and eccrine 
spiradenomas are different and so these fi  ndings might be 
used in making the differential diagnosis. 
In summary, we have described a rare case of a sweat 
gland tumor in the breast, an eccrine spiradenoma, with 
the use of imaging modalities, including mammography, US 
and MRI. Although an eccrine spiradenoma may resemble 
an epidermal inclusion cyst on mammography and US, 
there is a difference between the MRI fi  ndings of epidermal 
inclusion cysts and eccrine spiradenomas. 
REFERENCES
 1. Kersting DW, Helwig EB. Eccrine spiradenoma. AMA Arch Derm 
1956;73:199-227
 2. Ribeiro-Silva A, Shaletich C, Careta RS, Kazava DK, Siqueira 
MC, Ponton F. Spiradenocarcinoma of the breast arising in a 
long-standing spiradenoma. Ann Diagn Pathol 2004;8:162-166
 3. Leonard N, Smith D, McNamara P. Low-grade malignant eccrine 
spiradenoma with systemic metastases. Am J Dermatopathol 
2003;25:253-255
 4. Bosch MM, Boon ME. Fine-needle cytology of an eccrine 
spiradenoma of the breast: diagnosis made by a holistic 
approach. Diagn Cytopathol 1992;8:366-368
 5. Han YD, Huan Y, Deng JL, Zhang YG, Zhang CH. MRI 
appearance of multiple eccrine spiradenoma. Br J Radiol 
2007;80:E27-E29
 6. Dijkhuizen T, van den Berg E, Nikkels PG, Hoekstra HJ, de 
Jong B. Cytogenetics of a case of eccrine spiradenoma. Hum 
Pathol 1992;23:1085-1087
 7. Jin W, Kim GY, Lew BL, Yang DM, Kim HC, Ryu JK, et al. 
Sonographic fi  ndings of an eccrine spiradenoma: case report 
and literature review. J Ultrasound Med 2008;27:813-818
 8. Hong SH, Chung HW, Choi JY, Koh YH, Choi JA, Kang HS. MRI 
fi  ndings of subcutaneous epidermal cysts: emphasis on the 
presence of rupture. AJR Am J Roentgenol 2006;186:961-966
 9. Chen JT, Dahmash NS, Ravin CE, Heaston DK, Putman CE, 
Seigler HF, et al. Metastatic melanoma in the thorax: report of 
130 patients. AJR Am J Roentgenol 1981;137:293-298